Peptide Cycling: How Long to Run Each Peptide and When to Take a Break

Why Some Peptides Need Cycles

The biological reason for cycling is receptor sensitivity. When a receptor is stimulated continuously, cells often respond by reducing the number of available receptors at the cell surface. The signal is still being sent, but fewer receivers are listening. The result is tachyphylaxis: gradual loss of effect at the same dose. This is the pattern seen with chronic continuous stimulation of the GHRH and ghrelin receptors that growth hormone peptides target.

Cycling solves this by giving receptors time to upregulate back to baseline. A few weeks off is usually enough for the GHRH and ghrelin receptors to recover full sensitivity, after which the peptide works as well as it did at the start of the previous cycle. Without cycling, patients often find that month four feels like the peptide stopped working, when what actually happened is the receptors became less responsive.

Most other peptide classes do not face the same downregulation problem. Peptides that act as cofactors (NAD+) or signal molecules to existing pathways (MOTS-c, GHK-Cu) work through mechanisms that do not produce the same chronic-stimulation desensitization. They can be run continuously without losing effect. Peptides that drive specific repair (BPC-157, TB-500) are cycled for goal-based reasons rather than receptor reasons; once the injury heals, the peptide is no longer needed.

Growth Hormone Peptides

[CJC-1295/Ipamorelin](/blog/cjc-1295-ipamorelin-guide). The peptide most likely to need cycling. The standard protocol patterns:

— 3 months on, 1 month off. Run the full protocol for 12 weeks, then take a 4-week break before resuming. This is the most common cycling pattern in clinical practice.

— 5 days on, 2 days off (weekly). Inject Monday through Friday, take Saturday and Sunday off. Preserves weekly receptor sensitivity without longer breaks. Some providers prefer this for continuous GH support without the post-break adjustment period.

— Continuous with periodic 4-week breaks. Run continuously for 4 to 6 months, then take a 4-week break before resuming. This pattern is more aggressive and is usually used by patients with more advanced anti-aging protocols.

[Sermorelin](/blog/sermorelin-guide). Often cycled less aggressively than CJC-1295/Ipamorelin because the half-life is much shorter (about 10 minutes), so the receptor stimulation is naturally more pulsatile. Many patients run Sermorelin continuously for 6 to 12 months without a break, then take a 4-week pause.

[Tesamorelin](/blog/tesamorelin-guide). Typically run continuously for 6 to 12 months for visceral fat reduction, then evaluated. The original FDA-approved protocol for HIV lipodystrophy was continuous daily use without scheduled cycling. For off-label adult body composition use, some providers add a 4-week break every 6 months.

Repair Peptides (BPC-157, TB-500)

Repair peptides are cycled based on goal completion rather than receptor sensitivity. The framing is "how long does this injury or recovery need" rather than "how long can I keep stimulating this pathway."

[BPC-157](/blog/bpc-157-guide) acute injury course. 4 to 8 weeks of daily injection at the affected site or systemically, then discontinue when healing is satisfactory. For acute soft tissue injuries (sprains, strains, minor surgical recovery), 4 weeks is often enough. For chronic conditions that have failed to heal over months, 8 weeks is more typical.

BPC-157 gut protocol. 8 to 12 weeks for gastrointestinal issues like ulcers, IBD flares, or gut healing after long antibiotic courses. Oral capsules are sometimes used instead of injection for direct gut exposure. Continuous use beyond 12 weeks is rarely more effective than a repeat course after a break.

[TB-500](/blog/tb-500-guide) / [BPC-TB500 combo](/blog/bpc-tb500-guide). 4 to 6 weeks for soft tissue injury recovery. The combo product accelerates healing through complementary mechanisms (BPC-157 for angiogenesis and tendon healing, TB-500 for cell migration and inflammation modulation). Most patients see meaningful improvement within the first 3 weeks and complete the course at 6.

After the initial course, repair peptides are usually paused. If symptoms return, a repeat course can be initiated rather than running indefinitely. Continuous BPC-157 or TB-500 for months at a time is rarely the right approach; the peptide is most effective during active healing, less so as a maintenance therapy.

Anti-Aging Peptides

[Epitalon](/blog/epitalon-guide). The most distinctive cycling pattern of any peptide. The original Khavinson research used 10-day pulse courses with months between courses. The standard protocol is 10 days of daily injection, then a 3 to 6 month break before the next 10-day pulse. This pattern is unusual but is supported by the published evidence and is the default recommendation from most peptide-experienced providers.

[GHK-Cu](/blog/ghk-cu-guide). Run continuously for 3 to 6 months, evaluate, and continue or pause based on response. Receptor downregulation does not occur with GHK-Cu in the same way as GH peptides because the mechanism (gene expression modulation across thousands of genes) does not depend on a specific receptor that can desensitize.

[Thymosin Alpha-1](/blog/thymosin-alpha-1-guide). Can be run continuously for 6 to 12 months. The original international clinical protocols for chronic hepatitis used multi-year continuous courses without cycling. For adult anti-aging immune support, most providers use 3 to 6 month courses with periodic re-evaluation rather than indefinite continuous use.

[NAD+](/blog/nad-plus-guide). Continuous use is standard. The peptide-class effect of NAD+ comes from restoring the cellular cofactor pool, which is a continuous biological need. There is no receptor downregulation to worry about. Some patients use higher loading doses for the first month, then reduce to a maintenance dose.

Metabolic and Energy Peptides

MOTS-c. Run continuously. The mitochondrial signaling effect that drives MOTS-c benefits does not produce receptor desensitization. Most patients run MOTS-c for 6 to 12 months and evaluate, with continuation as long as the metabolic response is meaningful. Some providers cycle MOTS-c with NAD+, alternating which one is the primary peptide for 3 month periods, though there is no strong evidence this is better than running both continuously.

Glutathione. Continuous use. The antioxidant clearance effect is needed continuously, particularly for patients with chronic oxidative stress. Some patients use higher initial doses to "load" tissue glutathione, then reduce to a lower maintenance dose.

AOD-9604. Run for the duration of the body composition goal, typically 3 to 6 months. The fat-loss effect is the primary use case; once the target body composition is reached, AOD-9604 is usually discontinued rather than continued as a maintenance peptide.

Sexual Health Peptides

PT-141. Used on demand rather than daily. Inject 30 to 45 minutes before anticipated activity, no scheduled daily dosing. There is no cycling concept because the peptide is not in the system continuously. Frequency is determined by lifestyle and clinical need, not a protocol schedule.

Some providers prescribe scheduled daily PT-141 for patients with persistent low desire, but this is the exception rather than the rule. The on-demand pattern produces the same clinical effect with much lower cost and exposure.

Sleep Peptides

DSIP. Can be run continuously without receptor desensitization. Typical patterns are 3 to 6 month courses with re-evaluation. Some patients use DSIP only on nights when sleep quality has been poor, which is functional rather than scheduled cycling.

Selank / Pinealon / PE-22-28 blends. Continuous use is common. The neurological effects build over weeks of consistent use and there is no specific cycling requirement. Many patients run a blend continuously for 6 to 12 months as part of a broader sleep and cognitive protocol.

Cycling Stacks and Combinations

When patients run multiple peptides simultaneously, the cycling schedule depends on the specific combination. Some practical patterns:

CJC-1295/Ipamorelin + MOTS-c. Cycle the GH peptide on the standard 3 on / 1 off pattern. Run MOTS-c continuously through both phases. The MOTS-c continuity helps maintain the metabolic baseline during the GH break.

BPC-157 + TB-500 (recovery stack). Run together for 4 to 6 weeks for the active recovery phase, then discontinue together. There is no benefit to staggering the breaks; the recovery window is finished or it is not.

NAD+ + Glutathione. Both run continuously. There is no cycling interaction between them because neither peptide produces receptor desensitization.

Epitalon + GHK-Cu. Epitalon on the 10-day pulse pattern with months between courses. GHK-Cu runs continuously throughout. The two peptides work on completely different mechanisms and do not need synchronized cycling.

Frequently Asked Questions